Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
170.60    -2.60 (-1.50%)
Bid:
170.40
Ask:
170.80
Spread: 0.40 (0.235%)
Market Cap: £846.04m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Response to Press Speculation

17 Feb 2020 07:00

RNS Number : 1306D
Jupiter Fund Management PLC
15 February 2020
 

15 February 2020

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

Jupiter Fund Management Plc ("Jupiter" or the "Group")

 

RESPONSE TO PRESS SPECULATION

 

 

The Board of Jupiter notes the recent press speculation regarding a possible acquisition of Merian Global Investors ("Merian") and confirms that it is currently in advanced discussions with Merian and TA Associates regarding a potential acquisition of Merian. The Board of Jupiter sees this as an attractive opportunity to acquire a high quality independent active manager that would represent a strong fit with Jupiter in both investment management philosophy and culture. Merian had AUM of £22.4 billion as at 31 December 2019.

 

While discussions have been underway for some time and the Boards of both Jupiter and Merian are confident that the combination would have the potential to deliver meaningful benefits for the stakeholders of both businesses, discussions are ongoing and there can be no certainty these will lead to a transaction, nor as to the terms on which any such transaction would be concluded.

 

A further announcement will be made as and when appropriate.

 

This announcement contains inside information.

 

 

- ENDS -

 

For further information, contact: 

Jupiter Fund Management plc

Alex Sargent (Investor Relations) +44 (0) 20 3817 1534

Despina Constantinides (Media Relations) +44 (0) 20 3817 1278

 

Fenchurch Advisory Partners LLP (Lead Financial Adviser) +44 (0) 20 7382 2222

Vincent Bounie

Malik Karim

Philip Evans

 

J.P. Morgan Cazenove (Joint Financial Adviser and Corporate Broker) +44 (0) 20 7742 4000

Ed Squire

Andrew Stockdale

 

Powerscourt (Financial Communications Adviser to Jupiter) +44 (0) 20 7250 1446

Justin Griffiths

Victoria Heslop

 

LEI Number: 5493003DJ1G01IMQ7S28

 

 

About Jupiter

 

Jupiter is an independent, high conviction, active asset management business, managing mutual funds, segregated mandates and investment trusts on behalf of individuals and institutions across the UK and internationally. Its primary purpose is to help clients achieve their long-term investment objectives through delivering superior returns after all fees on client assets. Asset classes covered by the Group's funds include equities, fixed income, multi-asset, multi-manager and alternatives (including absolute return funds).

 

Jupiter is a market leading fund manager in the UK mutual fund market based on the size of its AUM and gross sales, its strong investment performance track record, the strength of its brand and presence in key distribution channels. As at 31 December 2019, approximately 88 per cent. of the Group's AUM was in mutual funds, the majority of which are open-ended funds directed towards investors through intermediated distribution channels in the UK, continental Europe, Asia and Latin America. In addition, it provides investment management services to institutional clients and investment trusts. The Group has offices in London, Hong Kong, Singapore, Austria, Germany, Italy, Luxembourg, Spain, Sweden and Switzerland.

 

As at 31 December 2019, the Group had approximately £42.8 billion of AUM, as compared to approximately £31.9 billion as at 31 December 2014. It was the seventh largest fund manager of UK retail funds under management as at 30 September 2019 (Source: The Investment Association).

 

 

 

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. This announcement has been prepared for the purposes of complying with the Listing Rules and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of England.

 

This announcement is not intended to, and does not constitute, or form part of, an offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. This announcement does not constitute a prospectus or a prospectus equivalent document. Shareholders of Jupiter and Merian are advised to read carefully the formal documentation in relation to the Acquisition once it has been despatched. Any response to the proposals should be made only on the basis of the information in the formal documentation to follow.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
SPCGCGDDDUBDGGU
Date   Source Headline
25th Mar 202011:29 amRNSHolding(s) in Company
19th Mar 20203:55 pmRNSDirector/PDMR Shareholding
17th Mar 20209:25 amRNSAnnual Financial Report
13th Mar 20203:15 pmRNSDirector/PDMR Shareholding
9th Mar 20203:54 pmRNSDirector Declaration
6th Mar 20209:00 amRNSDirector Shareholding
4th Mar 20203:40 pmRNSMajor Holdings Notification
3rd Mar 20203:00 pmRNSMajor Holdings Notification
2nd Mar 20204:05 pmRNSDirector Shareholding
28th Feb 20207:00 amRNSResults for the year ended 31 December 2019
17th Feb 20207:00 amRNSAcquisition
17th Feb 20207:00 amRNSResponse to Press Speculation
6th Nov 201910:00 amRNSDirectorate Change
11th Oct 20197:00 amRNSTrading Update and Notice of Results
30th Sep 201912:20 pmRNSDirector/PDMR Shareholding
9th Sep 20193:51 pmRNSDirector/PDMR Shareholding
5th Sep 20199:49 amRNSDirector/PDMR Shareholding
3rd Sep 20194:53 pmRNSConfirmation of appointment of Wayne Mepham
12th Aug 201911:58 amRNSDirector Declaration
12th Aug 201911:23 amRNSMajor Holdings Notification
30th Jul 20197:00 amRNSInterim Report and Accounts
1st Jul 20194:30 pmRNSEuropean Growth Strategy update
20th Jun 20195:04 pmRNSDirector/PDMR Shareholding
10th Jun 20193:48 pmRNSMajor Holdings Notification
30th May 201910:27 amRNSMajor Holdings Notification
16th May 20199:40 amRNSResult of AGM
14th May 20197:00 amRNSDirectorate Change
10th May 201912:31 pmRNSDirector Shareholding
8th May 20194:35 pmRNSDirector Shareholding
1st May 20194:41 pmRNSDirector Shareholding
30th Apr 20197:00 amRNSTrading Update and Notice of Results
17th Apr 20194:31 pmRNSDirector/PDMR Shareholding
16th Apr 20193:30 pmRNSDirector/PDMR Shareholding
10th Apr 20194:28 pmRNSPDMR Shareholding
8th Apr 20192:55 pmRNSDirector/PDMR Shareholding
4th Apr 20192:53 pmRNSPDMR Shareholding
29th Mar 20191:42 pmRNSNotice of Annual General Meeting
25th Mar 201911:27 amRNSPDMR Shareholding
18th Mar 20192:37 pmRNSDirector Shareholding
15th Mar 20193:29 pmRNSPDMR Shareholding
8th Mar 201911:36 amRNSDirector Shareholding
6th Mar 201911:02 amRNSMajor Holdings Notification
5th Mar 201912:25 pmRNSDirector Shareholding
4th Mar 20194:01 pmRNSPDMR Shareholding
4th Mar 201912:26 pmRNSDirector Shareholding
1st Mar 20197:00 amRNSResults for the year ended 31 December 2018
27th Feb 20194:09 pmRNSDirectorate Change Update
26th Feb 20197:00 amRNSDirectorate Change
13th Feb 201910:48 amRNSMajor Holdings Notification
22nd Jan 20197:00 amRNSChief Executive Officer Succession Planning

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.